Artal Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,028	Closed	-$436K	–	102
2023 Q2	$436K	Sell	5,028 -26,939	-84%	-$2.34M	0.01%	100
2023 Q1	$3.11M	Buy	+31,967	New	+$3.11M	0.18%	73
2021 Q2	–	Hold	0	–	–	–	143
2021 Q1	–	Hold	0	–	–	–	141
2020 Q4	–	Hold	0	–	–	–	129
2020 Q3	–	Hold	0	–	–	–	129
2020 Q2	–	Hold	0	–	–	–	119
2020 Q1	–	Hold	0	–	–	–	94
2019 Q4	–	Hold	0	–	–	–	89
2019 Q1	–	Hold	0	–	–	–	94
2018 Q4	–	Hold	0	–	–	–	83
2018 Q3	–	Hold	0	–	–	–	87
2018 Q2	–	Hold	0	–	–	–	83
2018 Q1	–	Hold	0	–	–	–	89
2017 Q4	–	Sell	-200,000	Closed	-$18.6M	–	90
2017 Q3	$18.6M	Sell	200,000 -50,000	-20%	-$4.65M	0.32%	11
2017 Q2	$22.7M	Sell	250,000 -75,000	-23%	-$6.81M	0.4%	9
2017 Q1	$28.5M	Sell	325,000 -25,000	-7%	-$2.19M	0.63%	6
2016 Q4	$29M	Buy	350,000 +50,000	+17%	+$4.14M	0.64%	6
2016 Q3	$27.8M	Sell	300,000 -50,000	-14%	-$4.63M	0.55%	8
2016 Q2	$27.2M	Sell	350,000 -50,000	-13%	-$3.89M	0.56%	8
2016 Q1	$33M	Buy	400,000 +125,000	+45%	+$10.3M	0.64%	7
2015 Q4	$28.8M	Sell	275,000 -165,000	-38%	-$17.3M	0.54%	7
2015 Q3	$46.3M	Buy	440,000 +5,000	+1%	+$527K	1.04%	5
2015 Q2	$59.5M	Sell	435,000 -45,000	-9%	-$6.16M	2.56%	3
2015 Q1	$59.8M	Hold	480,000	–	–	2.77%	3
2014 Q4	$43.4M	Sell	480,000 -70,000	-13%	-$6.33M	1.52%	4
2014 Q3	$39.7M	Buy	550,000 +25,000	+5%	+$1.8M	1.46%	4
2014 Q2	$32.7M	Hold	525,000	–	–	1.32%	4
2014 Q1	$35.8M	Buy	525,000 +125,000	+31%	+$8.53M	1.3%	5
2013 Q4	$28.1M	Buy	400,000 +150,000	+60%	+$10.6M	1.01%	5
2013 Q3	$18M	Sell	250,000 -100,000	-29%	-$7.22M	0.59%	9
2013 Q2	$19.5M	Buy	+350,000	New	+$19.5M	0.61%	10